Thermo Fisher Scientific (TMO) reported third quarter 2026 sales of $12.1 billion and net income of $1.7 billion. Its shares have gained 22.1% over 90 days and 18.8% so far this year. One-year total shareholder return stands at 26.6%. At a last close of $704.15, the stock trades about 3% above the $686.64 fair value set by the most followed narrative. Its price-to-earnings ratio of 36.8x compares with a fair ratio of 34.6x, a Global Life Sciences average of 38.1x, and a peer average of 40.1x. Risks include muted academic and government funding, and a longer drag on earnings from the microbiology divestiture.

People on the move: Katrina Downie joins Thermo Fisher Scientific as Vice President of Commercial BioProduction for North America. Thermo Fisher Scientific has welcomed Katrina Downie as Vice President, Commercial BioProduction Group (BPG), North America. In her new role, Downie will support the company's commercial operations and customer partnerships across its North American bioproduction business. "Excited for what lies ahead, and working with an outstanding team to support our clients and bring life saving therapies to patients. Look forward to continued partnerships and driving innovation in our field." About Katrina Downie. Downie brings more than two decades of experience in life sciences commercial leadership, with a background in bioprocessing, sales strategy, and customer engagement. Before joining Thermo Fisher Scientific, Downie served as Head of Commercial, BioProcess Solutions Americas at Sartorius. She previously held several leadership positions at MilliporeSigma, including Global Head of Commercial Operations for Life Science Services and Head of Commercial Operations for Process Solution Services across North America and Europe. Her experience also includes sales and commercial roles at BioReliance. She studied at the University of Strathclyde in Scotland. About Thermo Fisher Scientific. Thermo Fisher Scientific is a global life sciences company providing analytical instruments, laboratory equipment, bioproduction technologies, and pharmaceutical development services. Its BioProduction business supports biopharmaceutical manufacturers with technologies and services used throughout biologics development and manufacturing. The company's North American commercial organization works with customers developing and producing therapies, including biologics and advanced medicines. Stay in the loop. You'll get news for your region. Change topics or unsubscribe from any email.

Bailey Quinn Frank, 15, of Fort Lauderdale, Florida, won the $25,000 Thermo Fisher Scientific ASCEND Award, the top prize at the 2026 Thermo Fisher Scientific Junior Innovators Challenge. Thermo Fisher Scientific and Society for Science announced the winners in Washington, D.C. Frank built a low-cost environmental DNA sampler that uses a small fan and filter paper to collect airborne bacteria. She says it could help rural communities monitor health threats where resources for disease surveillance are limited. The 30 finalists, chosen from nearly 2,000 applicants, shared more than $100,000 in awards. Four other top winners each received $10,000, including twin brothers Henry and Jack Grover, 14, who developed a hydrogel sprayer to stop wildfires reigniting.